Silo Pharma, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $72,102 | $72,102 | $72,102 | $72,102 | — |
| Gross profit | $27,807 | $66,264 | $66,264 | $66,264 | $66,260 |
| Operating income | -$4.3M | -$4.7M | -$3.9M | -$3.6M | -$2.7M |
| Operating expenses | $4.3M | $4.8M | $3.9M | $3.7M | $2.8M |
| Cost of revenue | $44,295 | $5,838 | $5,838 | $5,838 | $5,004 |
| Cash from operations | -$4.7M | -$3.8M | -$3.2M | -$3.5M | -$2.3M |
| Impairments | $39,916 | — | — | — | — |
| Total assets | $7.6M | $7.4M | $7.7M | $11.6M | $10.5M |
| Total liabilities | $1.3M | $2.4M | $1.6M | $1.3M | $1.4M |
Shares outstanding 16.3M · Free float 98.7%
Annual filing data through FY ended December 31, 2025; float as of July 2, 2026.